We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

PHC Europe

PHC Europe BV, part of the PHC Corporation, Biomedical Division, manages sales, marketing, logistics and technical se... read more Featured Products: More products

Download Mobile App




Benchtop Immunoanalyzer Delivers Lab Quality Results for Cardiology, Intensive Care and Emergency Wards at POC

By HospiMedica International staff writers
Posted on 24 Oct 2022
Print article
Image: PATHFAST is a compact immunoanalyzer with superior assay performance (Photo courtesy of PHC Europe)
Image: PATHFAST is a compact immunoanalyzer with superior assay performance (Photo courtesy of PHC Europe)

A compact immunoanalyzer with superior assay performance combines the accuracy of a full-scale lab analyzer with the flexibility of a mobile solution, making it an ideal analysis system for laboratories, hospitals and medical offices where fast quantitative results (with full-scale lab quality) are required at the point of care.

The PATHFAST system from PHC Europe BV (Etten Leur, The Netherlands) is a fully automatic immunoassay analyzer, which combines the progressive chemiluminescence technology with the patented Magtration technology. PATHFAST provides fast, differential diagnosis and is easy to operate, install and network. Its high precision makes the analyzer an adequate “satellite” of a full-scale lab on a cardiology, intensive care or emergency ward. Parallel processing enables the examination of six samples in only a few minutes from whole blood, serum or plasma.

Six parallel channels give PATHFAST its unique speed with the ability to test for up to six different markers or a single marker for one or more patients’ samples in the same run. Whole blood can be used as sample material, eliminating laborious centrifuge routine, while plasma and serum can also be used. The use of whole blood saves time in obtaining the results while the patient is still at the point of care. Small sample volumes can be detected with high accuracy and precision. The device and the reagent strips provide optimum sensitivity. With its easy and intuitive design, PATHFAST offers an easy way to analyze patient samples by performing only three simple steps. The results are perfectly reproducible and correlate outstandingly with lab analysis.

Always safe and perfectly efficient, PATHFAST processes patient samples automatically and generates lab quality results without the need for additional reagents, buffer solutions or accessories (e.g. capillaries, cuvettes). It does not require water connection and drain, or any special skills, with only short training being sufficient to operate the PATHFAST. Other practical advantages are its highest operating safety and minimum maintenance expense.

Related Links:
PHC Europe BV

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Multilevel Self-Loading Stretcher
CARRERA XL

Print article

Channels

Critical Care

view channel
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

New Device Treats Acute Kidney Injury from Sepsis

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.